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Estrogenicity of Resin-based
Composites and Sealants in
Dentistry
The recent article "Estrogenicity of Resin-
based Composites and Sealants Used in
Dentistry," appearing in the March 1996
Environmental Health Perspectives (EHP
104:298-305) raises some familiar concerns
that critics of the profession have espoused.
Historically, many ofthe materials that have
been common in the dental armamentarium
have assumed their role through historical
acceptance. Bisphenol-A diglycidyl methacry-
late (bis-GMA) has been tested for safety and
efficacy at the ADA as a dental material. It
has never been assessed for its estrogenicity.
The thesis elaborated in this artide states that
the sealant and resin components bisphenol-
A and bisphenol-A dimethacrylate are estro-
genic and probably contribute to xenoestro-
gen exposure in humans.
The potential deleterious effects ofbisphe-
nol-A and its degradation products are well
documented. However, consideringpasthyste-
riaabout dental amalgam and the potential for
the spread ofcross-contamination-type infec-
tions, theneedshouldbeforscientificevidence
which will define ifrisk is present; and, ifso,
what is the gravity ofthat risk? Although the
research reportedwaswell done, it is aprelimi-
nary report. More comprehensive studies
should be undertaken that will identify the
potential for problems. Potential dangers that
bisphenol-A-containing dental products pos-
sess should be assessed through scientific
research. Hopefully, hysterical outcries form
thepresswill notoutweigh theneedforquality
investigation in this area. Programs that
encompass research at the laboratory bench
level should be undertaken and carried
through animal models, and finally, in situ
evaluation inhumansshould beelaborated.
As dental researchers, practicing wet fin-
gered dentists, and academics, we feel that
before conclusions are made condemning
composite resins and resin sealants, scientific
evidence should be gathered to deny or sub-
stantiate these concerns. As dental profession-
als who have seen dentistry criticized for the
use ofmercury in restoratives and the lack of
appropriate disinfection procedures for our
instruments and equipment, we feel that this
issue should be resolved through competent
scientific investigation. Hopefully, this issue
will be addressed in a more intellectual and
scientific manner than the emotion and hyste-
ria that has been the center ofsome issues in
dentistry in the recent past.
Charles M. Habib
Gerard Kugel
Department ofRestorative Dentistry
Tufts University School ofDental Medicine
Boston, Massachusetts
MTBE Toxicity
Robert Drew ofAPI wrote a letter to EHP
concerning EHP's feature artide on MTBE.
Rather than pointing out Mr. Drew's errors
and conclusions concerning the health dan-
gers of MTBE in gasoline, I would like to
respond by presenting the Collegium
Ramazzini's position on this issue. I believe
the annexed statement speaks for itself.
The Collegium Ramazzini, an independent
organization dedicated to occupational health,
and comprised ofinternationally renowned
physicians and scientists from 30 countries
(induding the United States, Sweden, Finland,
Germany, Japan, Canada, Italy, Belgium, and
China), sponsors special conferences focusing
on new developments that may impact public
healthandtheenvironment.
On November 3, 1995, the Oil
Chemical andAtomic Workers International
Union (OCAW) and Collegium Ramazzini
held a special scientific conference in
Washington, D.C. where papers were sub-
mitted on the health effects of the motor
gasoline additives methyl tertiary butyl ether
(MTBE) and 1,3-butadiene.
Methyl tertiary butyl ether (MTBE) is a
gasoline additive used principally during
winter months. It comprises 11-15% of
gasoline. Because of new federal regulations,
it is being used in steadily increasing
amounts in the United States. In 1979, agal-
lon ofpremium gasoline sold in the United
States contained about 3% of the additive
MTBE in about 10% ofcars. Because ofthe
Clean Air Act. oxygenated (reformulated)
gasoline is sold in nine U.S. cities with the
worst smog problems and in 17 states.
Nearly one quarter of all gasoline sold
through the country contains this additive.
In 1992, the annual production of MTBE
was 10.86 billion pounds (approximately
72,000 barrels perday).
A major regulatory failure is that MTBE
was not adequately tested for either acute or
chronic toxic effects before it was added in
significant quantities to gasoline. Many con-
sumers and workers, when exposed to gaso-
line containing MTBE, complain ofextreme
headaches, vomiting, diarrhea, fever, cough,
muscle aches, sleepiness, disorientation,
dizziness, and skin and eye irritation. MTBE
is known to cause central nervous system
(CNS) depression, tremors, ataxia, labored
breathing, chronic inflammation of nasal
mucosa, eye irritation, andskin rashes (1).
MTBE may also increase risk of cancer,
and this risk was not adequately assessed
prior to introducing this product into com-
merce. Recent studies by Belpoggi et al. (2)
have shown that oral exposure to MTBE
causes dose-related, statistically significant
increases of lymphoma and leukemias, and
of testicular Leydig cell cancers in rats. In
1992, Burleigh-Flayer et al. (3) reported that
inhalation exposure to MTBE caused an
increase in the number of liver tumors in
mice. In males, there was a statistical increase
in carcinomas, while in females, there was a
statistically significant increase in adenomas.
In 1992, Chun et al. (4) reported a statisti-
cally significant increase in kidney tumors in
male rats after inhalation exposure. MTBE
causes cancers in many organs and tissues of
two species of experimental animals; these
cancers are similar to those caused by expo-
sures of comparable dose of benzene, vinyl
chloride, and 1,3-butadiene, all recognized
carcinogens.
There is general agreement among
experts in chemical carcinogenesis that a sub-
stance which causes cancer in significant
numbers of experminental animals in well-
conducted assays poses a presumptive car-
cinogenic risk to some humans, even in the
absence of conformatory epidemiological
data.
The Collegium Ramazzini concludes
that exposure to MTBE in gasoline should
be avoided in order to prevent needless ill-
nesses or both consumers and workers. The
Collegium Ramazzini urges that the toxicity
ofMTBE be fully and vigorously examined.
It is not prudent to permit wide environ-
mental releases of a compound that may
cause acute illness aswell as cancer.
Myron A. Mehiman
Collegium Ramazzini
North American Secretariat
Princeton, NewJersey
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